Article Information
History
- June 4, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Alexandra Tauzin1,2,
- Lorie Marchitto1,2,
- Étienne Bélanger1,2,
- Mehdi Benlarbi1,2,
- Guillaume Beaudoin-Bussières1,2,
- Jérémie Prévost1,2,
- Derek Yang3,
- Ta-Jung Chiu3,
- Hung-Ching Chen3,
- Catherine Bourassa1,
- Halima Medjahed1,
- Marek K Korzeniowski4,
- Suneetha Gottumukkala4,
- William D. Tolbert4,
- Jonathan Richard1,2,
- Amos B Smith III3,
- Marzena Pazgier4 and
- Andrés Finzi1,2,*
- 1Centre de Recherche du CHUM, Montreal, QC, Canada
- 2Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, QC, Canada
- 3Department of Chemistry, School of Arts and Sciences, University of Pennsylvania, Philadelphia, PA, USA
- 4Infectious Diseases Division, Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
- ↵*Corresponding author: Andrés Finzi, andres.finzi{at}umontreal.ca
Posted June 04, 2024.
Three families of CD4-induced antibodies are associated with the capacity of plasma from people living with HIV to mediate ADCC in presence of CD4-mimetics
